Latest Breaking News On - Robertb stein - Page 2 : vimarsana.com

Protagenic Therapeutics, Inc : Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics, Inc : Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesGaroh armenRobertb steinDennis riedlAndrew sleeProtagenic therapeutics incCompany contactAdvisory incCall scheduledProtagenic therapeuticsChief medical officerChief operating officerToll freeAccess codeCorticotropin releasing factor

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics, Inc. , a biopharmaceutical innovator, announced that the Company plans to hold its first investor earnings call to discuss the results contained in its FY 2023 Form 10K, which it plans to file that day, and its outlook for FY.

New yorkUnited statesAndrew sleeGaroh armenRobertb steinCompany contactProtagenic therapeutics incAdvisory incProtagenic therapeuticsChief medical officerChief operating officerToll freeAccess codeCorticotropin releasing factorLooking statementsProtagenic therapeutic

Protagenic Therapeutics Achieves First Clinical Safety Milestone with

Protagenic Therapeutics Achieves First Clinical Safety Milestone with .

New yorkUnited statesRobertb steinCompany perspectiveProtagenic therapeutics incNews networkCompany contactAdvisory incProtagenic therapeuticsClinical protocol progressTreatment resistant depressionGeneralized anxietyComprehensive approachStrategic collaborationAxiom real time metricsData analytics

Protagenic Therapeutics, Inc : Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Protagenic Therapeutics, Inc : Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesStefan klotterRobertb steinAdvisory incCompany contactProtagenic therapeutics incCompany perspectiveProtagenic therapeuticsProtocol progressTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaPrincipal investigator

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114
clevelandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clevelandstar.com Daily Mail and Mail on Sunday newspapers.

United statesRobertb steinProtagenic therapeutics incDepartment of psychiatry at massachusettsExchange commissionDean for clinical translational researchProtagenic therapeuticsTrial focusTreatment resistant depressionGeneralized anxietyAxiom real time metricsData analyticsMaurizio favaMassachusetts general hospitalAssociate deanTranslational research